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Objectives. The purpose of this investigation was to derive 
population-based reference values for M-mode echocardiographie 
dimensions that can be applied in epidemiologic studies, clinical 
trials and clinical practice and to determine optimal methods for 
adjusting these dimensions for body size. 
Background. M-mode eehocardiography remains an mportant 
modality for studying cardiovascular disease; this is especially 
true with regard to detecting target organ damage in systemic 
hypertension. Most previously p blished reference values were 
derived from hospital-based series or relatively small samples and 
were not gender specific. 
Methods. Using a sample of 288 men and 524 women who were 
between 20 and 45 years of age and who were free of cardiovas- 
cular disease, reference values were derived for end-diastolic and 
end-systolic left ventricular internal dimensions, left ventricular 
wall thickness and left atrial dimension. The relations between 
these dimensions and height, a measure of body size relatively 
independent ofobesity, were investigated using various regression 
models. 
Results. Nomograms for mean and 95th percentile values in 
men and women were constructed on the basis of linear egression 
models relating echocardiographic dimensions to he ght. Adjust- 
ment for body surface area greatly attenuated associations be. 
tween obesity and cardiac dimensions in a separate healthy but 
less restricted sample of 411 men and 503 women. 
Conclusions. Gender-specific M-mode reference values and 
nomograms, with mean and95th percentile values for echocar- 
diographic dimensions as a function of height, are reported. The 
use of body surface area as means of body size adjustment is 
called into question. 
(J Am Coil Cardiol 1995;26:1039-46) 
M-mode echocardiography remains an important modality for 
studying cardiovascular disease in population studies, clinical 
trials and investigations of hypertensive disease (1-6). For 
echocardiography to be a more effective pidemiologic tool, it 
would be helpful to have well defined gender-specific reference 
values derived from healthy subjects within population-based 
samples. Previously published reference values (7-9) were 
derived from hospital-based series or relatively small samples 
and were not gender-specific. 
This report presents reference echocardiographic values for 
several important cardiac dimensions in a healthy subset of the 
Framingham Heart Study. Any consideration of normal car- 
diac dimensions must take into account the known interactions 
between cardiac size and body size, which in previous reports 
has been assessed using height, body surface area, weight and 
estimated lean body mass (10,l 1). Therefore, the relations of 
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height and M-mode left ventricular dimensions are explored. 
Height was chosen as a measure of body size because it is 
obesity independent and may represent a readily available 
surrogate for lean body mass, which as been shown to be 
associated with cardiac size (12). 
Methods  
Study samples. Study esign and selection criteria for the 
Framingham Heart Study and Framingham Offspring Study 
have been described previously (13-15). The original cohort 
comprised a sample of adult residents of Framingham, Mas- 
sachusetts between the ages of 28 and 62 years; since 1948, 
these subjects have undergone biennial examinations. Off- 
spring of the original cohort and spouses of offspring were 
enrolled in 1972. Data for this investigation were obtained as 
part of examination 16 (1979 to 1982) of the original cohort 
and examination 2 (1979 to 1983) of the offspring cohort. 
Written informed consent was obtained from all subjects 
before the study. 
Two subsets of examinees were studied: a "healthy, re- 
stricted" sample and a "healthy, less restricted" sample; crite- 
ria for similar samples have been described elsewhere (16). 
Briefly, members of the healthy, restricted sample had to be 
between ages 20 and 45 years, between 1.5 and 1.9 m in height 
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in men or between 1.4 and 1.8 m in height in women, free of 
cardiovascular disease and hypertension (i.e., systolic blood 
pressure <140 mm Hg, diastolic blood pressure <90 mm Hg 
and taking any antihypertensive medications), not currently 
using any cardiovascular medications, not diabetic, not obese 
(body mass index between 19 and 26 kg/m 2) and had to have a 
technically adequate echocardiogram. Members of the healthy, 
less restricted sample had only to be free of overt cardiovas- 
cular disease (i.e., no signs or symptoms of cardiovascular 
disorders), not taking any cardiovascular medications and had 
to have a technically adequate chocardiogram. Thus, the 
major difference between the two samples was whether or not 
body size restrictions were applied: the healthy, less restricted 
sample had no body size requirements. Criteria for cardiovas- 
cular diagnoses and diabetes have been detailed elsewhere 
(17,18). 
To avoid overlap between the healthy, restricted and 
healthy, less restricted samples, all subjects were split randomly 
into two groups (one group comprising 75% of the study 
sample, and the other group 25%). From the 75% subset, we 
derived the healthy, restricted sample that was used for model 
fitting, whereas from the 25% subset we d rived the healthy, 
less restricted sample. 
Baseline measurements. Examinations routinely included 
measurements of height, weight and blood pressure. Rest 
systolic and diastolic blood pressures were measured in the left 
arm of seated subjects using a mercury column sphygmoma- 
nometer. Two physician-measured systolic and diastolic pres- 
sures were averaged to derive rest systolic and diastolic blood 
pressures. Body surface area was calculated using the Dubois 
formula (19): body surface area (m a) = (0.0001) × (71.84) × 
(weight, kg) 1~'425 × (height, cm) c~725. Body mass index (kg/m 2) 
was used as an index of obesity. 
Echocardiographic methods. Standard M-mode methods 
were used as previously reported (20-22). End-diastolic and 
end-systolic measurements of left ventricular internal dimen- 
sion, interventricular septal thickness, posterior f ee wall thick- 
ness and left atrial dimension were obtained using the Amer- 
ican Society of Echocardiography convention (21). The left 
ventricular wall thickness was defined as the sum of the 
thicknesses of the interventricular septum and the posterior 
free wall. In >90% of the echocardiograms, two-dimensional 
images were used to guide M-mode measurements. 
Statistical methods. The healthy, restricted sample was 
used to estimate reference values, whereas the healthy, less 
restricted sample was studied to assess the clinical impact of 
height and body surface area adjustment methods. Gender- 
specific mean values and standard eviations were calculated 
for baseline characteristics of both samples. 
Gender-specific regression analyses were performed to 
investigate the relations between left ventricular M-mode 
dimensions and height. Height was chosen as a measure of 
body size because unlike body surface area, it is relatively 
independent of obesity. In the healthy, less restricted sample, 
body surface area was correlated strongly with body mass index 
(r = 0.61 for men; r = 0.72 for women), but height was only 
minimally correlated with body mass index (in men r = -0.09 
for men; r = -0.13 for women). 
Three methods of regression were used (23). 1) Standard 
linear regression: Y = /3 o + /31 × height + E, where/3o = Y 
intercept; /3 t = slope; and E = an error term. 2) Log-linear 
modeh log Y = /30 + /3J ×, log(height) + E. 3) Nonlinear 
regression: Y =/3o × Heig htt~ + E. To compare these models, 
the R 2 and root-mean-square errors were calculated; for the 
log-linear model, estimates were converted back to original 
units to calculate the root-mean-square error. In addition, 
residuals and fitted values from each model were examined 
graphically. 
Examination of the fitted plots, the root-mean-square er-
rors and the R 2 values revealed that none of the three models 
showed any clear superiority. Furthermore, residuals from the 
linear model appeared to have constant variance and also 
normal distribution (except for wall thickness in women). For 
greatest simplicity, therefore, to construct nomograms the 
standard linear models were used. For each gender and left 
ventricular M-mode dimension (except wall thickness in 
women and left atrial dimension i  both genders, which yielded 
nonsignificant regressions [men] with very low R 2 values), 
nomograms of mean and upper 95th percentile values were 
made, plotting the fitted M-mode values against height (using 
ranges 1.55 to 1.90 m in men, 1.45 to 1.80 m in women). The 
upper 95th percentile was approximated by predicted value 
plus 1.65 times root-mean-square e ror. 
To determine the clinical impact of different body size 
considerations, Pearson correlation coefficients relating left 
ventricular M-mode variables to systolic blood pressure and 
body mass index were calculated in the healthy, less restricted 
sample. Simple correlations, partial correlations adjusted for 
height and partial correlations adjusted for body surface area 
were computed. Because age and cardiovascular disease limi- 
tations were used to define the healthy, less restricted sample, 
analyses regarding age and cardiovascular diseases were not 
performed. 
All analyses were performed on a SUN Sparcstation2 using 
the SAS 6.07 statistical p ckage (24). Regression analyses were 
performed using the PROC REG and PROC NLIN proce- 
dures. All analyses were gender-specific. 
Results 
Characteristics of subjects (healthy, restricted an healthy, 
less restricted samples). The clinical characteristics of the 
study subjects are summarized in Table 1. The healthy, re- 
stricted sample included 288 men and 524 women; the healthy, 
less restricted sample included 411 men and 503 women. 
Compared with the healthy, restricted sample, the healthy, less 
restricted sample was older, heavier, had a larger body mass 
index and body surface area, higher blood pressure and larger 
left ventricular wall thickness, left ventricular mass and left 
atrial dimension but had similar diastolic and systolic left 
ventricular cavity dimensions. Whereas none of the subjects in 
the healthy, less restricted sample had any signs or symptoms 
JACC Vol. 26, No. 4 LAUER ET AL. 1041 
October 19'45:1(139-46 M-MODE REFERENCE VALUES 
Table 1. Clinical Characteristics of the Healthy', Restricted and Healthy, Less Restricted Study Samples 
Healthy, Restricted Sample Healthy, Less Restricted Sample 
Men (n 28;8) Women (n = 524) Men (n 411) Women (n = 503) 
Mean SD Mean SD Mean SD Mean SD 
Age (yr) 35.7 6.1 35.9 
Height (m) 1.77 0.06 1.63 
Weight (kg) 74.1 t~.9 59.3 
Body mass index (kg/m e) 23.5 1.6 22. I 
Body surface area (m e) 1.91 I).11 1.64 
Systolic blood pressure (mm Hg) 117 9.1 I lit 
Diastolic blood pressure (mm Hg) 74.8 6.8 711.9 
LV diastolic dimension (mm) 511.8 3.6 46.1 
LV systolic dimension (mm) 323) 3.4 28.9 
LV wall thickness (mm) IS. 1 2.0 15.5 
LA dimension (mm) 37.5 3.6 33.1 
5.5 46.3 12.8 47.5 13.2 
0.06 1.75 0.07 1.61 0.06 
6.1 81t.7 12.0 62.2 11.4 
1.7 26.1 3.4 23.9 4.2 
0.10 1.96 0.16 1.65 0.14 
10.5 124 15.6 119 17.3 
7.5 78.8 8.8 74.3 8.5 
3.() 51.1 3.7 45.7 3.6 
2.8 32.9 3.5 28.3 3.2 
1.5 19.2 2.6 16.7 2.5 
3.2 39.6 4.2 34.3 4.2 
LA = left atrial; LV - Icft ventricular. 
of cardiovascular disease, 133 (15%,) did meet the criteria for 
hypertension (systolic blood pressure _> 140 mm Hg or diastolic 
blood pressure ->90 mm Hg; by definition no subjects were 
taking antihypertensive medications). 
Left ventricular M-mode dimensions and height (healthy, 
restricted sample). Summaries of regression analyses relating 
left ventricular M-mode dimensions to height are shown in 
Tables 2 and 3. Except for left ventricular wall thickness in 
Table 2. Three Regression Models Relating Left Ventricular M-Mode Echocardiographic Dimensions 
to Height Derived From Men in the Healthy, Restricted Study Sample 
Estimated/~ p 
LV Dimension Estimated ,8. 195r.4 C1) R e RMSE Value 
Mode(: LV Dimension = ,8. - /3 t Height + E 
LV diastolic 21.36 16.63 0.08 3.460 0.0001 
dimension ( I{1.1-23.2 ) 
LV systolic dimension 12.60 11.47 0.114 3.3117 (I.01/04 
(5.2 17.7) 
IN wall thickness 2.70 8.68 0.07 1.930 0.01101 
(5.0-12.3) 
LA dimension 29.21/ 4.69 0.01 3.619 11.1812 
(2.2-11.5) 
Model: log(LV dimension) /3. + /31 log(Height) + E 
LV diastolic " 3.611 0.57 0.08 3.463 0.(/1101 
dimension (0,34-0.N)) 
LV systolic dimension 3.15 (}.61/ 0.04 3.312 0.0005 
(0.26-0.94) 
LV wall thickness 2.41 {}.84 0.07 1.932 0.0001 
(11.49 1.18) 
LA dimension 3.49 (}.22 0.01 3.624 0.1758 
( 0.10 0.55) 
Model: LV Dimension = /3,~ Height ¢~ + E 
LV diastolic 36.51 0.58 0.08 3.461 0.000l 
dimension (1t.35 0.81 ) 
LV systolic dimension 23.13 I).62 0.04 3.308 0.0003 
{(I.28-11.96) 
LV wall thickness I 1.14 11.85 0.07 1.930 0.000l 
(0A9-1.21) 
LA dimension 33.09 1L22 0.01 3.619 0.1819 
([I.10-(L54) 
RMSE - root-mean-square e ror: other abbreviations as in Table 1. 
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Table 3. Three Regression Models Relating Left Ventricular M-Mode Dimensions to Height Derived 
From Women i  the Healthy, Restricted Study Sample 
Estimated/3 t p 
LV Dimension Estimated/3ql (95% C1) R 2 RMSE Value 
Model: LV Dimension = 13. + /3~ Height + E 
LV diastolic dimension 23.48 13.85 0.07 2.903 0.0001 
(9.7-18.01 
LV systolic dimension 9.51 11.91 0.116 2.707 0.0001 
(S.0-15.8) 
LV wall thickness 9.26 3.84 0.02 1.511 0.0006 
(1.7- 6.0) 
LA dimension 22.83 6.27 11.01 3.175 0.0076 
(1.7-10.8) 
Model: log(LV dimension) - /3 o + /3~ log(Height) + E 
LV diastolic dimension 3.59 11,50 0.08 2.905 0.000l 
(0.35-0.65/ 
LV systolic dimension 3.03 (I.68 0.06 2.709 0.0001 
(0.45-0.90) 
LV wall thickness 2.54 0.41 0.02 1.510 0.0004 
(ll. 19-0,64) 
LA dimension 3.34 0.31 0.01 3.172 0.0083 
(0.08-0.53) 
Model: LV Dimension : ~3,) Height ¢~ + E 
LV diastolic dimension 36.26 11.49 0.07 2.903 0.0001 
(ii.34 (/.64) 
LV systolic dimension 211.85 0.67 0.06 2.707 0.0001 
(0,45-0.89) 
kV wall thickncss 12.74 0.40 0.02 1.511 0.0006 
(0.17-0.63) 
LA dimension 28.42 0.31 0.01 3.175 0.0075 
(0.08-(I,53) 
Abbreviations as in Tables 1 and 2. 
women, all models yielded normally distributed residuals. The 
nonnormality ofresiduals for left ventricular wall thickness was 
due to the small number of distinct values. Examination of 
residuals, root-mean-square errors and fitted values revealed 
that all three models were essentially equivalent. Therefore, 
simple linear regression models were used to derive nomo- 
grams for M-mode dimensions. 
The confidence intervals for 13~ for left atrial dimension in 
men for two of three models included zero, and the slope 
estimates were quite small. This finding suggests that the 
relation between left atrial dimension and height is minimal. 
Nomograms (healthy, restricted sample). Figures 1 to 3 
provide gender-specific nomograms relating left ventricular 
M-mode dimensions to height. The upper lines refer to the 
95th percentile values, and the lower lines refer to mean 
values. All lines were derived from the linear egression 
models in Table 2. Thus, these lines can be used to determine 
an upper "normal" value for any given height. The predicted 
upper normal values were compared with the original data set 
for each cardiac dimension. For all dimensions except left 
ventricular wall thickness in women, both the predicted and 
actual data were comparable, with roughly 5c4 of the sample 
categorized asabnormal. Among women, asubstantial number 
had left ventricular wall thickness (sum of interventricular 
septum and posterior wall) measured at 18 ram, such that 
choosing >18 mm as a cutoff yielded only 2% abnormally high, 
whereas choosing a cutoff ->18 yielded 11% abnormally high. 
Clinical implications of differing body size measurements 
(healthy, less restricted sample). Table 4 showscorrelation 
coetficients between left ventricular M-mode dimensions and 
systolic blood pressure in the healthy, less restricted sample. 
Moderate correlations were noted for left ventricular wall 
thickness and left atrial dimension with systolic blood pressure. 
Using partial correlations adjusted for height or body surface 
area resulted in little change. For example, adjusting for height 
increased the correlation between left ventricular wall thick- 
ness and systolic blood pressure from 0.27 to 0.30 in men and 
did not change the correlation i  women (0.46). 
Table 5 shows simple and partial correlation coefficients for 
M-mode dimensions and body mass index in the healthy, less 
restricted sample. Moderate correlations were noted for left 
ventricular wall thickness and left atrial dimension with body 
mass index. Using partial correlations adjusted for height 
resulted in slight increases in the correlation coefficients; in 
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Figure 1. Nomogram plots of predicted mean and 95th percentile 
(95%ile) values for left ventricular (LV) end-diastolic dimension as a 
function of height for men (top) and women (bottom), derived from 
linear regression models in Tables 2 and 3. Values above the 95th 
percentile for any given height may be considered abnormally high. 
contrast, adjusting for body surface area resulted in marked 
attenuation of correlations, especially between M-mode di- 
mensions and body mass index. For example, adjusting for 
body surface area decreased the correlation of left atrial 
dimension and body mass index in women from 0.49 to 0.34. 
These observations are not surprising, given the correlation of 
body surface area with body mass index (see Statistical meth- 
ods). 
The data from Tables 4 and 5 suggest that in the setting of 
obesity, the use of body surface area as a method of adjusting 
cardiac dimensions may be inappropriate. For correlations of 
cardiac dimensions and systolic blood pressure, body size 
adjustment seems to make little difference. 
Discuss ion  
In a young, healthy, population-based sample, we derived 
reference values and nomograms for echocardiographic left 
ventricular internal dimensions and wall thickness that can be 
used for future epidemiologic studies, clinical trials and clinical 
practice. These values can potentially be used in M-mode 
echocardiographic studies of the effects of obesity, cardiovas- 
41 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  ; . . . . . . . . . . .  , 
i 95%i le  i 
o 37 
Q 
._E 35 . . . . . . . . . . . . . . . . . . . . . .  i . . . . . . . . . . . .  ! . . . . . . . . . . .  i . . . . . . . . . . . . . . . . . . . . . . .  , - -Mean-i  
a 
[ 33 
ffl 
~ 31 
29 i 
1.55 1.60 1.65 1.70 1.75 1.80 1.85 1.90 
Height  (m) 
37 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  ~ . . . . . . . . . .  
! 95%i le 
._o 33 
. -  31 
._~ 
29 
~ 27 
25 
1.45 1.50 1.55 1.60 1.65 1.70 1.75 1.80 
Height  Im) 
Figure 2. Nomogram plots of predicted mean and 95th percentile 
(95%ile) values for left ventricular (LV) end-systolic dimension as a 
function of height for men (top) and women (bnttom), derived from 
linear regression models in Tables 2 and 3. Values above the 95th 
percentile for any given height may be considered abnormally high. 
cular disease processes, hypertension a d various medications 
on cardiac structure and function. They may have important 
implications for population-based studies. Also, these models 
can be used to define continuous measures of left ventricular 
dimensions in study or clinical populations by utilizing the 
observed values versus those predicted from the regression 
models in the healthy, restricted population. 
As echocardiographic techniques have advanced from M- 
mode to two-dimensional and, more recently, three- 
dimensional techniques (25,26), it might be argued that this 
type of M-mode research is rapidly becoming irrelevant. We 
believe that this is not so. Quantitative M-mode echocardiog- 
raphy remains widely used in most echocardiography labora- 
tories. Furthermore, M-mode echocardiography still plays an 
important role in cardiovascular research. For example, M- 
mode techniques figured prominently in the methods and 
tables of two recent articles on clinical hypertension and 
cardiac structure (5,6). M-mode techniques also were used in 
recent reports from the Cardiovascular Health Study (2,27) 
and a widely cited study of physiologic hypertrophy in athletes 
1044 LAUER ET AL. JACC Vot. 26, No. 4 
M-MODE REFERENCE VALUES October 1995:1039-46 
22 
21 
20 
t~ 
,X 
u 
> 
-1 
16 
iiiiiiiii  i i i!il .... 
1.55 1.60 1.65 1.70 1.75 1.80 1.85 1.90 
Height (m) 
Figure 3. Nomogram plots of predicted mean and 95th percentile 
(95%ile) values for left ventricular (LV) wall thickness in men as a 
function of height, derived from linear regression models in Table 2 
and 3. Values above the 95th percentile for any given height may be 
considered abnormally high. 
(28). Furthermore, M-mode measurements have been found to 
be powerful predictors of cardiovascular p ognosis (29-32). 
How to adjust echocardiographic dimensions optimally for 
body size remains controversial (16,33,34). We previously 
reported (16) height indexation of cchocardiographic left 
ventricular mass derived from a log-log regression model. 
Here we showed that adjusting for body surface area may 
inappropriately attentuate the relation between M-mode left 
ventricular mass and obesity; this finding may be especially 
important given the impact of even mild to moderate degrees 
of obesity on left ventricular mass and geometry (35). In 
contrast, a recent study (34) of 611 normotensive adults and 
253 hypertensive patients demonstrated that height-based in- 
dexes of M-mode left ventricular mass maintained, and possi- 
bly enhanced, the association of increased left ventricular mass 
with an adverse cardiovascular p ognosis. 
There is some impact of height on left ventricular M-mode 
cavity dimensions and on left ventricular wall thickness (in 
particular in men). Left atrial dimension, however, has only a 
minimal relation with height, as demonstrated bythe very low 
R 2 values for the regression models; for this reason we do not 
present nomograms of left atrial size. The powers < 1 noted in 
Tables 2 and 3 suggest hat simple indexation of M-modc 
dimensions (e.g., left ventricular diastolic dimension/height as 
a distinct variable) is inappropriate. 
Previous investigations. Triulzi et al. (9) reported refer- 
ence values of M-mode and two-dimensional echocardio- 
graphic dimensions in 72 volunteers 15 to 76 years old. 
Feigenbaum (36) reported reference M-mode values based on 
130 adults, whereas Schnittger et al. (7) studied 35 adults, 
and Henry et al. (8) studied 136 adults. Compared with those 
investigations, the current study had a much larger sample of 
apparently healthy subjects. Also, we performed separate 
analyses for men and women. 
Devereux et al. (10) investigated the association of left 
ventricular dimensions to body size and lean body mass in 92 
hospital-based and 133 population-based subjects. Indexes of 
body size considered included height, weight, body surface 
area, weight/height ratio, poneral index and body mass index. 
All echocardiographic measurements were found to correlate 
most closely with body surface area. In addition, when lean 
body mass, as estimated by 24-h urine creatinine xcretion, was 
considered, gender differences in M-mode estimated left ven- 
tricular mass were eliminated. 
In a very intriguing study involving 196 children and 72 
adults, Nidorf et al. (37) reported that height was the best 
predictor of aortic annular size, left atrial dimension, left 
ventricular end-diastolic dimension and left ventricular length 
(as assessed by the apical two-chamber view). In a multivari- 
able model, including age, gender, height, weight and body 
surface area, only height was independently predictive of 
cardiac dimensions. The association of cardiac dimensions with 
height was weaker in the current study than in that by Nidorf 
et al., probably because the current study included only adults, 
and thus the variance of height was substantially smaller. 
Study limitations. The study sample was overwhelmingly 
white and European in ancestry, so the reported reference 
values may not apply to nonwhite, non-European populations. 
Although this is an acknowledged limitation, data from the 
Framingham Heart Study and other homogeneous white pop- 
ulations continue to provide valuable contributions, as evi- 
denced, for example, by two recent publications on isolated 
borderline systolic hypertension (in the Framingham Study) 
(38) and on asthma mortality (in Olmstead County) (39). 
The age restrictions do not allow us to define separate 
"reference" values in elderly patients. A potential problem in 
defining separate reference values in the elderly stems from 
Table 4. Correlations of Left Ventricular Dimensions With Systolic Blood Pressure in the H althy, Less Restricted Study Sample 
Correlation With Systolic Blood Pressure inMen Correlation With Systolic Blood Pressure inWomen 
Partial Adjusted Partial Adjusted Partial Adjusted Partial Adjusted 
LV Dimension Simplc for Height for BSA Simple for Height for BSA 
LV diastolic dimension 0.10 (I. 15" 0.09 0.1 lt - 0.05 -0.14' 
LV systolic dimension 0.04 0.09 0.(14 0.13" -0.08 -0.16:~ 
LV wall thickness 0.27, 11.30~ 11.27~ 0.46, 0.46:1: 0.47:1: 
LA dimension 0.24, 11.24- il.24, 0.26, 0.25, 0.26:~ 
*p < 0.01. )p < 0.05.5:p <0.001. BSA body surface area: other abbreviations as in Table 1. 
JACC Vol. 26, No. 4 LAUER ET AL. 1045 
October 1995:1039-46 M-MODE REFERENCE VALUES 
Table 5. Correlations of Left Ventricular Dimensions With Body Mass Index in the Healthy, Less Restricted Study Sample 
Correlation With Body Mass Index in Men Correlation With Body Mass Index in Women 
Partial Adjusted Partial Adjusted Partial Adjusted Partial Adjusted 
LV Dimension Simple for Height for BSA Simple for Height for BSA 
LV diastolic dimension 0.25* 0.28* 0.04 0.24* 0.30* -0.07 
LV systolic dimension 0.17" 0.19' -0.01 0.19" 0.23* -0.09"1" 
LV wall thickness 0.33' 0.35' 0.19" 0.40* 0.40* 0.30* 
LA dimension 0.46* 0.46* 0.35* 0.49* 0.49* 0.34* 
*p < 0.001. tp < 0.05. Abbreviations a  in Tables 1 and 4. 
pathologic effects of aging and comorbid isease (i.e., factors 
other than body size) on left ventricular geometry (40). 
The R 2 values, which were mostly statistically significant, 
are quite low; nonetheless, they are comparable to those 
relating left ventricular mass to systolic blood pressure, a well 
recognized and accepted clinically important association. 
Some of the regressions, particularly for left atrial dimension, 
did not give statistically significant slopes; height-based nomo- 
grams were therefore not generated for those situations. 
The results of the log-linear and nonlinear regressions are 
remarkable for powers < 1,similar to previous observations by 
de Simone et al. (41). These findings suggest that upper limits 
of normal cardiac dimensions as a function of height may lose 
accuracy compared with nomograms that take into account 
curvilinear relations, assuming that the latter are correct. In 
our data, examination of fitted values and residuals, root- 
mean-square errors and R 2 values revealed that none of the 
three models showed any clear superiority. Therefore, the 
standard linear models were used to construct nomograms. 
Conclusions. We report gender-specific population-based 
reference M-mode values and nomograms based on a healthy 
sample of Framingham Heart Study subjects. Although two- 
and three-dimensional echocardiographic techniques are rap- 
idly improving, the results of the present study are important 
because M-mode echocardiography is still widely used in 
clinical practice and, more important, it continues to figure 
prominently in epidemiologic studies, clinical trials and clinical 
investigations of hypertensive disease. Th issue of body size 
indexation, which we previously studied for echocardiographic 
left ventricular mass (16), is explored with regard to linear 
echocardiographic dimensions. The use of body surface area 
adjustment is called into question once again because it masks 
obesity-related alterations in cardiac geometry. 
We thank James D. Thomas, MD, FACC, Cleveland Clinic Foundation, for 
helpful review and criticisms of the manu~ript. 
References 
1. Lauer MS, Evans JC, Levy D. Prognostic implications of ubclinical left 
ventricular dilatation and systolic dysfunction in men free of overt cardio- 
vascular disease. Am J Cardiol 1992;70:1180-4. 
2. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: 
design and rationale. Ann Epidemiol 1991;l:263-76. 
3. Pearson AC, Gudipati C, Nagelhout D, Sear J, Cohen JD, Labovitz AJ. 
Echocardiographic evaluation of cardiac structure and function in elderly 
subjects with isolated systolic hypertension. J Am Coil Cardiol 1991;17:422- 
30. 
4. Koren M J, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of 
left ventricular mass and geometry to morbidity andmortality in uncompli- 
cated essential hypertension. Ann Intern Med 1992;114:345-52. 
5. Gottdiener JS, Reda DJ, Materson BJ, et al. Importance ofobesity, race and 
age to the cardiac structural and functional effects of hypertension. 
J Am Coil Cardiol 1994;24:1492-8. 
6. Chaturvedi N, Athanassopoulos G, McKeigue P, Marmot M, Nihoyanno- 
poulos P. Echocardiographic measures of left ventricular structure and their 
relation with rest and ambulatory blood pressure in blacks and whites in the 
United Kingdom. J Am Coil Cardiol 1994;24:149%505. 
7. Schnittger I, Gordon EP, Fitzgerald PJ, Popp RL. Standardized intracardiac 
measurements of two-dimensional echocardiography. J Am Coll Cardiol 
1983;2:934-8. 
8. Henry WL, Gardin JM, Ware JH. Echocardiographic measurements in 
normal subjects from infancy to old age. Circulation 1980;62:1054-61. 
9. Triulzi M, Gillam LD, Gentile R, Newell JB, Weyman AE. Normal adult 
cross-sectional echocardiographic values: linear dimensions and chamber 
areas. Echocardiography 1984;1:403-26. 
10. Devereux RB, Lutas EM, Casale PN, et al. Standardization f M-mode 
echocardiographic left ventricular anatomic measurements, J Am Coil 
Cardiol 1984;4:1222-30. 
II. de Simone G, Devereux RB, Roman M J, Alderman MH, Laragh JH. 
Relation of obesity and gender to left ventricular hypertrophy innormoten- 
sive and hypertensive adults. Hypertension 1994;23:600-6. 
12. Hammond IW, Devereux RB, Alderman MH, Laragh JH. Relation of blood 
pressure and body build to left ventricular mass in normotensive and 
hypertensive employed adults. J Am Coil Cardiol 1988;12:9%-1004. 
13. Dawber TR, Kannel WB, Lyell LP. An approach to longitudinal studies in a 
community: the Framingham Study. Ann NY Acad Sci 1983;107:539-56. 
14. Dawber TR, Meadors GR, Moore FE. Epidemiologic approaches to heart 
disease: the Framingham Heart Study. Am J Public Health 1951;41:279-86. 
15. Kannel WB, Feinlieb M, McNamara PM, Garrison RJ, Castelli WP. An 
investigation of coronary heart disease in families: the Framingham Off- 
spring Study. Am J Epidemiol 1979;110:281-90. 
16. Lauer MS, Anderson KM, Larson MG, Levy D. A new method for indexing 
left ventricular mass for differences in body size. Am J Cardiol 1994;74:487- 
91. 
17. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic 
implications of echocardiographicalty determined left ventricular mass in the 
Framingham Heart Study. N Engl J Med 1990;322:1561-6. 
18. Shurtleff D. Some characteristics related to the incidence of cardiovascular 
disease and death: the Framingham Study 18-year follow-up. In: Kannel WB, 
Gordon T, editors. The Framingham Study: An Epidemiologic Investigation 
of Cardiovascular Disease, Section 30 (DHEW publication No. (NIH) 
74-599). Washington (D.C.): Government Printing Orifice, 1974. 
19. Dubois D, Dubois EF. A formula to estimate the approximate surface area 
if height and weight are known. Arch Intern Med 1916;17:863-71. 
20. Feigenbaum H. Echocardiography. 3rd ed. Philadelphia: Lea & Febiger, 
1981:51-118. 
21. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding 
quantitation i M-mode echocardiography: results of a survey of echocar- 
diographic measurements. Circulation 1978;58:1072-83. 
22. Savage DD, Garrison R J, Kannel WB, Anderson SJ, Feinlieb M, Castelli 
WP. Considerations in the use of echocardiography in epidemiology: the 
Framingham Study. Hypertension 1987;9: Suppl. II:II-40-4. 
1046 LAUER ET AL. JACC Vo[. 26, No. 4 
M-MODE REFERENCE VALUES October 1995:1039-46 
23. Draper NR, Smith H. Applied Regression Analysis. 2rid ed. New York: 
Wiley, 1981:1-47, 141-53, 169-71,222-5, 458-89. 
24. SAS Institute. SAS/STAT User's Guide. Version 6, 4th ed., Vol. 2. Cary, 
(NC): SAS Institute Inc.. 1989:1135-94, 1351-456. 
25. Gopal A, Keller AM, Shen Z, Sapin P, et al. Three-dimensional echocardi- 
ography: in vitro and in vivo validation of left ventricular mass and 
comparison with conventional echocardiographic methods. J Am Coil Car- 
diol 1994;24:504-13. 
26. Mensah GA, Byrd BF 111. Heart size: one-. two-, and now three-dimensional 
echocardiography. J Am Coil Cardiol 1994;24:514-6. 
27. Psaty BM, Furberg CD, Kuller LH, ct al. Isolated systolic hypertension and 
subclinical cardiovascular disease in th  elderly: initial finding from the
Cardiovascular Health Study. JAMA 1992;268:1287-91. 
28. Pelliccia A, Maron BJ, Spataro A, Proschan MA, Spirito P. The upper limit 
of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J 
Med 1991;324:295-301. 
29. Galderisi M, Lauer MS, Levy D. Echocardiographic determinants of clinical 
outcome in subjects with coronary arte 9 disease: the Framingham Heart 
Study. Am J Cardiol 1992;7(1:971-6. 
30. Lauer MS, Evans JC, t.evy D. Prognostic implications of left ventricular 
dilatation and systolic dysfunction in men free of overt cardiovascular 
disease. Am J Cardiol 1992;70:1180-4. 
31. Ghali JK, Liao Y, Simmons B, Castanet A, Cat) G. Cooper RS. The 
prognostic role of left ventricular hypertrophy patients with or it out 
coronary artery disease. Ann Intern Meal 1992;117:831-6. 
32. Bikkina M, Levy D, Evans JC, et al. Left ventricular mass nd risk of stroke 
in an elderly cohort: the Framingham Heart Study. JAMA 1994;272:33-6. 
33. Gutsegell HP, Rembold CM. Growth of the human heart relative to body 
surface area. Am J Cardiol 1990;65:662-8. 
34. de Simone G, Devereux RB, Daniels SR, Koren M J, Meyer RA, Laragh JH. 
Effect of growth on variability of left ventricular mass: assessment of 
allometric signals in adults andchildren and their capacity to predict 
cardiovascular risk. J Am Coil Cardiol 1995;25:1065-2. 
35. Lauer MS, Anderson KM, Kannel WB, Levy D. The impact of obesity on left 
ventricular mass and geometry: the Framingham Heart Study. JAMA 
1991;266:231-6. 
36. Feigenbaum H. In ref. 20:549-50. 
37. Nidorf SM, Picard MH, Triulzi MO, et al. New perspectives in the
assessment of cardiac chamber dimensions during development and adult- 
hood. J Am Coil Cardiol 1992;19:983-8. 
38. Sagie A, Larson MG, Levy D. The natural history of borderline isolated 
systolic hypertension. N Engl J Med1993;329:1912-7. 
39. Silverstein MD, Reed CF, O'Connell EJ, Melton IA III, O'Fallon MO, 
Yunginger JW. Long-term survival of a cohort of community residents with 
asthma. N Engl J Med 1994;331:1537-41. 
40. Wei JY. Age and the cardiovascular system. N Engl J Med 1992;327:1735-9. 
41. de Simone G, Daniels SR, Devereux RB, ct al. Left ventricular mass and 
body size in normotensive children and adults: assessment of allometric 
relations and impact of overweight. J Am Coil Cardiol 1992;20:1251-60. 
